Penserra Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Penserra Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-53,407	Closed	-$5.88M	–	818
2018 Q3	$5.88M	Buy	+53,407	New	+$5.56M	0.36%	66
2018 Q1	–	Sell	-92,815	Closed	-$8.45M	–	540
2017 Q4	$8.45M	Buy	+92,815	New	+$7.72M	1.11%	26
2017 Q3	–	Sell	-5,932	Closed	-$444K	–	622
2017 Q2	$444K	Sell	5,932 -5,919	-50%	-$410K	0.16%	108
2017 Q1	$773K	Buy	+11,851	New	+$698K	0.08%	90
2016 Q4	–	Sell	-22,857	Closed	-$1.29M	–	979
2016 Q3	$1.29M	Buy	+22,857	New	+$1.12M	0.16%	35

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Penserra Capital Management's PRAH Position: Q4 2018 in Review

Penserra Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 53,407 shares — an estimated $5.88M sold.

Penserra Capital Management first reported a position in PRAH in Q3 2016 and held it in 5 quarters. The position peaked at $8.45M in Q4 2017. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

Penserra Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
Penserra Capital Management sold 53,407 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $5.88M.
Penserra Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 5 quarters.
Penserra Capital Management's PRA Health Sciences, Inc. position peaked at $8.45M in Q4 2017.
334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on Penserra Capital Management's 13F filing for Q4 2018, filed 6 Feb 2019.